Literature DB >> 2119076

Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitus.

L J García Frade1, H de la Calle, M C Torrado, J I Lara, L Cuellar, A García Avello.   

Abstract

The pathogenesis of diabetic vasculopathy has been related to modifications in hemostasis and fibrinolysis. 50 non insulin dependent diabetes mellitus patients have been studied. Euglobulin clot lysis time, fibrin plate, tissue plasminogen activator (t-PA) antigen, plasminogen activator inhibitor (PAI) activity, Protein C and S, cholesterol, triglycerides and Hb A1c were determined in blood samples. Diabetic patients showed decreased fibrinolytic activity, as measured by ECLT, with clearly increased PAI levels. Fibrinolytic response to venous occlusion was lower than normal. Vascular complications were associated both with an even higher PAI activity and with a decreased fibrinolytic response to venous occlusion. Elevated PAI activity and decreased fibrinolytic response to stimulus may contribute to vascular disease in diabetes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2119076     DOI: 10.1016/0049-3848(90)90270-m

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

1.  Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients.

Authors:  C Giusti; R Schiaffini; C Brufani; A Pantaleo; E M Vingolo; P Gargiulo
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

Review 2.  Fibrinolysis Shutdown in Trauma: Historical Review and Clinical Implications.

Authors:  Hunter B Moore; Ernest E Moore; Matthew D Neal; Forest R Sheppard; Lucy Z Kornblith; Dominik F Draxler; Mark Walsh; Robert L Medcalf; Mitch J Cohen; Bryan A Cotton; Scott G Thomas; Christine M Leeper; Barbara A Gaines; Angela Sauaia
Journal:  Anesth Analg       Date:  2019-09       Impact factor: 5.108

3.  Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.

Authors:  A Mormile; M Veglio; G Gruden; M Girotto; P Rossetto; P D'Este; P Cavallo-Perin
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

4.  Detection of early allograft dysfunction at 30 min of reperfusion in liver transplantation: An intraoperative diagnostic tool with real time assessment of graft function.

Authors:  Hunter B Moore; Hillary Yaffe; James J Pomposelli; Michael Wachs; Thomas Bak; Peter Kennealey; Kendra Conzen; Megan Adams; Thomas Pshak; Rashikh Choudhury; Carson Walker; Alexander Schulick; Tanner Ferrell; Michael P Chapman; Elizabeth A Pomfret; Trevor L Nydam
Journal:  Am J Surg       Date:  2020-08-27       Impact factor: 2.565

5.  Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1.

Authors:  V Martina; G A Bruno; E Zumpano; C Origlia; L Quaranta; G P Pescarmona
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

6.  Lupus anticoagulant positivity in insulin dependent diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy?

Authors:  C Giusti; R Schiaffini; D Bosco; P Ciampalini; A Pantaleo; E M Vingolo; P Gargiulo
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

7.  Anticoagulant protein C activity in non-insulin-dependent diabetic patients with normoalbuminuria and microalbuminuria.

Authors:  M Veglio; G Gruden; A Mormile; M Girotto; P Rossetto; P D'Este; P Cavallo-Perin
Journal:  Acta Diabetol       Date:  1995-06       Impact factor: 4.280

8.  Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity.

Authors:  Katarina Lalić; Aleksandra Jotić; Nataša Rajković; Sandra Singh; Ljubica Stošić; Ljiljana Popović; Ljiljana Lukić; Tanja Miličić; Jelena P Seferović; Marija Maćešić; Jelena Stanarčić; Milorad Čivčić; Iva Kadić; Nebojša M Lalić
Journal:  Int J Endocrinol       Date:  2015-05-18       Impact factor: 3.257

9.  Plasma t-PA and PAl-1 antigen concentrations in non-insulin dependent diabetic patients: effects of treatment modality on fibrinolysis.

Authors:  Y W Cho; D H Yang; D Y Oh; S H Baick; S K Kim; S J Kim; S Y Hong
Journal:  Korean J Intern Med       Date:  1992-07       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.